PIBF: The Double Edged Sword. Pregnancy and tumor

American Journal of Reproductive Immunology

Volumn 64, Issue 2, 2010, Pages 77-86

  Szekeres Bartho, Julia ^a   Polgar, Beata ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cytokine; PIBF; Pregnancy; Progesterone

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; INTERLEUKIN 4 RECEPTOR; JANUS KINASE; MESSENGER RNA; PERFORIN; PHOSPHOLIPASE A2; PROGESTERONE; PROGESTERONE INDUCED BLOCKING FACTOR; PROGESTERONE RECEPTOR; STAT PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; PIBF1 PROTEIN, HUMAN; PLACENTA PROTEIN; SUPPRESSOR FACTOR;

ARACHIDONIC ACID METABOLISM; CANCER SURVIVAL; CELL CYCLE REGULATION; CYTOKINE PRODUCTION; DECIDUA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LEUKEMIA; LOW DRUG DOSE; LYMPHOCYTE; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL RATE; TH2 CELL; UTERUS CONTRACTION; ANIMAL; CELL TRANSFORMATION; FEMALE; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACID; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; FEMALE; HUMANS; IMMUNOMODULATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHOSPHOLIPASES A2; PREGNANCY; PREGNANCY PROTEINS; PROGESTERONE; RECEPTORS, PROGESTERONE; SUPPRESSOR FACTORS, IMMUNOLOGIC;

EID: 77958105597     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00833.x     Document Type: Review

References (96)

1. Moriyama I, Sugawa T: Progesterone facilitates implantation of xenogenic cultutred cells in hamster uterus. Nature New Biol 1972; 236:150-152.
2. Hansen PJ, Bazer FW, Segerson EC: Skin graft survival in the uterine lumen of ewes treated with progesterone. Am J Reprod Immunol Microbiol 1986; 12:48-54.
3. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites DP: Progesterone and the maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann NY Acad Sci 1977; 286:384-397
4. Staples LD, Heap RB: Studies on steroids and proteins in relation to the immunology of pregnancy in the sheep. In Immunological Aspects of Reproduction in Mammals, DB Crighton (ed.). London, Butterworths, 1984, pp 195-205.
5. Stites DB, Bugbee S, Siiteri PK: Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation.-Relevance to immunosuppression in pregnancy. J Reprod Immunol 1983; 5:215-228.
6. Schiff RI, Mercier R, Buckley RH: Inability of gestational hormones to account for the inhibitory effects of pregnancy plasmas on lymphocytes responses in vitro. Cell Immunol 1978; 20:69-80.
7. Csapo AI, Wiest WG: An examination of the quantitative relationship between progesterone and the maintenance of pregnancy. Endocrinology 1969; 85:735-746.
8. Szekeres-Bartho J, Hadnagy J, Pacsa AS: The suppressive effect of progesterone on lymphocyte cytotoxicity: unique progesterone sensitivity of pregnancy lymphocytes. J Reprod Immunol 1985; 7:121-128.
9. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G: Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989; 122:281-294.
10. Hansen KA, Opsahl MS, Nieman LK, Baker Jr JR, Klein TA: Natural killer cell activity from pregnant subjects is modulated by RU 486. Am J Obstet Gynecol 1992; 166:87-90.
11. Szekeres-Bartho J, Szekeres GY, Debre P, Autran B, Chaouat G: Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990; 125:273-283.
12. Polgar B, Barakonyi A, Xinos I, Szekeres-Bartho J: The role of γ/δ TCR positive cells in pregnancy. Am J Reprod Immunol 1999; 41:239-244.
13. Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Zs, Palkovics T, Szereday L: The role of γ/δ T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 1999; 42:44-48.
14. Szekeres-Bartho J, Reznikoff-Etievant MF, Varga P, Pichon MF, Varga Z, Caouat G: Lymphocytic progesterone receptors in normal and pathological human pregnancy. J Reprod Immunol 1989; 16:239-247.
15. Szekeres-Bartho J, Weill BJ, Mike G, Houssin D, Chaouat G: Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol Letters 1989; 22:259-261.
16. Chiu L, Nishimura M, Ishi Y, Nieda M, Maeshima M, Takedani Y, Tadokoro K, Juji T: Enhancement of the expression of progesterone receptor on progesterone - treated lymphocytes after immunotherapy in unexplained recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:552-557.
17. Szekeres-Bartho J, Kinsky R, Kapovic M, Chaouat G: Complete Freund adjuvant treatment of pregnant females influences resorption rates in CBA/JxDBA/2 mating via progesterone mediated immunomodulation. Am J Reprod Immunol 1991; 26:82-83.
18. Tangri S, Raghupathy R: Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod 1993; 49:850-856.
19. Robertson SA, Mau VJ, Hudson SN, Tremellen KP: Cytokine-leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol 1997; 37:438-442.
20. Daya S, Clark DA: Immunosuppressive factor (or factors) produced by human embryos in vitro. N Engl J Med 1986; 24:1551-1552.
21. Kelemen K, Paldi A, Tinneberg H, Torok A, Szekeres-Bartho J: Early recognition of pregnancy by the maternal immune system. Am J Reprod Immunol 1998; 39:351-355.
22. Bazer FW, Spencer TE, Ott TL: Interferon Tau: a novel pregnancy recognition signal. Am J Reprod Immunol 1997; 37:412-420.
23. Bazer FW, Spencer TE, Ott TL: Placental interferons. Am J Reprod Immunol 1996; 35:297-308.
24. Toder V, Strassburger D, Irlin I, Carp H, Pecht M, Trainin N: Nonspecific immunopotentiators and pregnancy loss: complete Freund Adjuvant reverses high fetal resorption rate in CBA/JxDBA/2 mouse combination. Am J Reprod Immunol 1990; 24:63-66.
25. Guillaudeux T, Rodriguez AM, Girr M, Mallet V, Ellis SA, Sargent IL, Fauchet R, Alsat E, Le Bouteiller P: Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J Immunol 1995; 154:3283-3299.
26. Le Bouteiller P: HLA class I chromosomal region, genes and products: facts and questions. Crit Rev Immunol 1994; 14:89-129.
27. Mincheva Nilsson L, Baranov V, Yeung MMo-Way, Hammarstrom S, Hammarstrom M-L: Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy. J Immunol 1994; 152:2020-2032.
28. Liu WJ, Gottshall SL, Hansen PJ: Increased expression of cell surface markers on endometrial γ/δ T cell receptor intraepithelial lymphocytes induced by the local presence of the sheep conceptus. Am J Reprod Immunol 1997; 37:199-205.
29. Meeusen E, Fox A, Brandon M, Lee CS: Activation of uterine intraepithelial gamma delta T cell receptor positive lymphocytes during pregnancy. Eur J Immunol 1993; 23:1112-1117.
30. Kimura M, Hanawa H, Watanabe H, Ogawa M, Abo T: Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell Immunol 1995; 162:15-25.
31. Born W, Hall L, Dallas A, Boymel J, Shinnick T, Young D, Brennan P, O'Brien R: Recognition of a Peptide antigen by Heat Shock-reactive γ/δ T lymphocytes. Science 1990; 240:67-69.
32. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA: Recognition of cluster differentiation I antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 1989; 341:447-450.
33. Faure F, Jitsukawa S, Miossec C, Hercend T: CD1c as a target recognition structure for human T lymphocytes; analysis with peripheral blood γ/δ cells. Eur J Immunol 1990; 20:703-706.
34. van Kaer L, Wu M, Ichikawa Y, Ito K, Bonneville M, Ostrand-Rosenberg S, Murphy DB, Tonegawa S: Recognition of MHC TL gene products by γ/δ T cells. Immunol Rev 1991; 120:89-115.
35. Weintraub BC, Jackson MR, Hedrick SM: γ/δ T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J Immunol 1994; 153:3051-3058.
36. Barakonyi A, Kovacs KT, Miko E, Szereday L, Varga P, Szekeres-Bartho J: Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy. J Immunol 2002; 168:2683-2688.
37. De León-Nava MA, Nava K, Soldevila G, López-Griego L, Chávez-Ríos JR, Vargas-Villavicencio JA, Morales-Montor J: Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J Steroid Biochem Mol Biol 2009; 113:57-64.
38. Butts CL, Shukair SA, Duncan KM, Bowers E, Horn C, Belyavskaya E, Tonelli L, Sternberg EM: Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol 2007; 19:287-296.
39. Dosiou C, Hamilton AE, Pang Y, Overgaard MT, Tulac S, Dong J, Thomas P, Giudice LC: Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 2008; 196:67-77.
40. Henderson TA, Saunders PT, Moffet-King A, Grrome NO, Critchley HO: Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003; 88:440-449.
41. Arruvito L, Giulianelli S, Flores AC, Paladino N, Barboza M, Lanari C, Fainboim L: NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol 2008; 180: 5746-5753.
42. Yamamoto K: Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 1985; 19:209-252.
43. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa AS: Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 1985; 9:15-18.
44. Polgar B, Kispal GY, Lachmann M, Paar C, Nagy E, Csere P, Miko E, Szereday L, Varga P, Szekeres-Bartho J: Molecular cloning and immunological characterization of a novel cDNA coding for PIBF. J Immunol 2003; 171:5956-5963.
45. Lachmann M, Gelbmann D, Kálmán E, PolgárB, Buschle M, von Gabain A, Szekeres-Barthó J, Nagy E: PIBF (Progesterone Induced Blocking Factor) is overexpressed in highly proliferating cells and associated with the centrosome. Int J Cancer 2004; 112:51-60.
46. Raghupathy R: Th-1 type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
47. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:77-86.
48. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R: Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000; 15:713-718.
49. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1-and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122-130.
50. Rezaei A, Dabbagh A: T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit 2002; 8:CR607-CR610.
51. Hossein H, Mahroo M, Abbas A, Firouzeh A, Nadia H: Cytokine production by peripheral blood mononuclear cells in RM. Cytokine 2004; 28:83-86.
52. Wilson R, Moor J, Jenkins C, Miller H, Walker JJ, McLean MA, Norman J, McInnes B: Abnormal first trimester serum interleukin 18 levels are associated with a poor outcome in women with a history of RM. Am J Reprod Immunol 2004; 51:156-159.
53. Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS: Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum Reprod 2002; 17:2439-2444
54. Raghupathy R, Al Mutawa E, Makhseed M, Azizeh F, Szekeres-Bartho J: Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent abortion. BJOG 2005; 112:1096-1101.
55. Kalinka J, Szekeres-Bartho J: The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. Am J Reprod Immunol 2005; 53:166-171.
56. Szereday L, Varga P, Szekeres-Bartho J: Cytokine production in pregnancy. Am J Reprod Immunol 1997; 38:418-422.
57. Joachim R, Zenclussen AC, Polgar B, Douglas AJ, Fest S, Knackstedt M, Klapp BF, Arck PC: The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 2003; 68:931-940.
58. Szekeres-Bartho J, Wegmann TG: A progesteronedependent immuno-modulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996; 31:81-95.
59. Kozma N, Halasz M, Polgar B, Poehlmann TG, Markert UR, Palkovics T, Keszei M, Kiss K, Szeberenyi J, Par G, Grama L, Szekeres-Bartho J: PIBF activates STAT6 via binding to a novel IL-4 receptor. J Immunol 2006; 176:819-826.
60. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4. Stat Sci 1994; 265:1701-1706.
61. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996; 93:497-501.
62. Caput D, Laurent P, Kaghad M, Lelias J, Lefort S, Vita N, Ferrara P: Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor _ chain. J Biol Chem 1996; 271:16921-16926.
63. Zurawski S, Chomarat MP, Djossous O, Bidaud C, McKenzie AN, Miossec PJ, Banchereau J, Zurawski G: The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995; 270:13869-13878.
64. Horejsi V, Cebecauer M, 'Cerny JE, Brdiejka T, Angelisova P, Drbal K: Signal transduction in leucocytes via GPI-anchored proteins: an experimental artefact or an aspect of immunoreceptor function? Immunol Lett 1998; 63:63-73
65. Alfieri JA, Martin AD, Takeda J, Kondoh G, Myles DG, Primakoff P: Infertility in female mice with an oocyte-specific knockout of GPI-anchored proteins. J Cell Sci 2003; 116:2149-2155.
66. Labeta M, Margni R, Leoni J, Binaghi R: Structure of asymmetric non-precipitating antibody: presence of a carbohydrate residue in only one Fab region of the molecule. Immunology 1986; 57:311-317.
67. Margni R, Binaghi R: Non-precipitating asymmetric antibodies. Annu Rev Immunol 1988; 6:535-554.
68. Kelemen K, Bognar I, Paal M, Szekeres-Bartho J: A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 1996; 167:129-134.
69. Lje SJ, Porter DG: Demonstration that progesterone blocks uterine activity in the ewe in vivo by a direct action on the myometrium. J Reprod Fertil 1978; 52:87-94.
70. Csapo AI: The see-saw theory of parturition. Ciba Found Symp 1997; 47:159-210.
71. Szekeres-Bartho J, Hadnagy J, Pacsa AS: Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155:108-112.
72. Par G, Geli J, Kozma N, Varga P, Szekeres-Bartho J: Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2. Am J Reprod Immunol 2003; 49:1-5.
73. Szekeres-Bartho J, Csernus V, Hadnagy J, Pacsa AS: Progesterone-prostaglandin balance influences lymphocyte function in relation to pregnancy. Am J Reprod Immunol 1983; 4:139-141.
74. Par G, Bartok B, Szekeres-Bartho J: Cyclooxygenase is involved in the effect of Progesterone Induced Blocking Factor (PIBF) on IL-12 production. Am J Obstet Gynecol 2000; 183:126-130.
75. Luchetti CG, Mikó E, Szekeres-Bartho J, Paz DA, Motta AB: Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice. J Steroid Biochem Mol Biol 2008; 111:200-207.
76. Szekeres-Bartho J, Csernus V, Hadnagy J, Pacsa AS: Influence of treatment with prostaglandin synthesis inhibitor or progesterone on cytotoxic activity and progesterone binding capacity of lymphocytes during pregnancy. Prostaglandins 1983; 26:187-195.
77. Kinsky R, Delage G, Rosin N, Thang MN, Hoffmann M, Chaouat G: A murine model of NK cell mediated resorption. Am J Reprod Immunol 1990; 23:73-77.
78. Szekeres-Bartho J, Kinsky R, Chaouat G: The effect of a progesterone induced immunologic blocking factor on NK-mediated resorption. Am J Reprod Immunol 1990; 24:105-107.
79. Szekeres-Bartho J, Par G, Dombay Gy, Smart YC, Volgyi Z: The anti-abortive effect of PIBF in mice is manifested by modulating NK activity. Cell Immunol 1997; 177:194-199.
80. Laskarin G, Tokmadzić VS, Strbo N, Bogović T, Szekeres-Bartho J, Randić L, Podack ER, Rukavina D: Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol 2002; 48:201-209.
81. Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J: Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999; 42:71-75.
82. Szekeres-Bartho J, Kinsky R, Chaouat G: A progesterone-induced immunologic blocking factor corrects high resorption rate in mice treated with antiprogesterone. Am J Obstet Gynecol 1990; 163:1320-1322.
83. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achacz I: Progesterone and non-specific immunological mechanisms in pregnancy. Am J Reprod Immunol 1997; 38:176-182.
84. Anderle C, Hammer A, Polgár B, Hartmann M, Wintersteiger R, Blaschitz A, Dohr G, Desoye G, Szekeres-Barthó J, Sedlmayr P: Human trophoblast cells express the immunomodulator progesterone-induced blocking factor. J Reprod Immunol 2008; 79:26-36.
85. Polgár B, Nagy E, Mikó É, Varga P, Szekeres-Barthó J: Urinary PIBF (Progesterone Induced Blocking Factor) concentration is related to pregnancy outcome. Biol Reprod 2004; 71:1699-1705.
86. Check JH, Levin E, Bollendorf A, Locuniak J: Miscarriage in the first trimester according to the presence or absence of the progesterone-induced blocking factor at three to five weeks from conception in progesterone supplemented women. Clin Exp Obstet Gynecol 2005; 32:13-14.
87. Check JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH: Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception. Am J Reprod Immunol 1997; 38:6-8.
88. Check JH, Arwitz M, Gross J, Peymer M, Szekeres-Bartho J: Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF). Am J Reprod Immunol 1997; 37:17-20.
89. Salomon LJ, Rozenberg P, Szekeres-Bartho J, Malagrida L, Giudicelli Y, Ville Y: Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks. J Matern Fetal Neonatal Med 2005; 17:353-356.
90. Coussons-Read ME, Okun ML, Nettles CD: Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun 2007; 21:343-350.
91. Arck PC, Rose M, Hertwig K, Hagen E, Hildebrandt M, Klapp BF: Stress and immune mediators in miscarriage. Hum Reprod 2001; 16:1505-1511.
92. Blois S, Ilarregui JM, Tometten M, Garcia M, Orsal AF, Toscano M, Handjiski B, Tirado I, Markert UR, Poirier F, Szekeres-Bartho J, Rabinovich G, Arck P: A pivotal role for galectin-1 in fetal tolerance. Nat Med 2007; 13:1450-1457.
93. Arck PC, Rücke M, Rose M, Szekeres-Bartho J, Douglas AJ, Pritsch M, Blois SM, Pincus MK, Bärenstrauch N, Dudenhausen JW, Nakamura K, Sheps S, Klapp BF: Early risk factors for spontaneous abortion: a prospective cohort study in pregnant women. Reprod Biomed Online 2008; 17:101-113.
94. Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson JT, Syrjakoski K, Weaver D, Haraldsson K, Johannsdottir HK, Vehmanen P, Nigam S, Golberger N, Robbins C, Pak E, Dutra A, Gillander E, Stephan DA, Bailey-Wilson J, Juo SH, Kainu T, Arason A, Barkardottir RB, Nevanlinna H, Borg A, Kallioniemi OP: A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes. Hum Genet 2002; 110:111-121.
95. Check JH, Sansoucie L, Chern J, Amadi N, Srivastava M, Larece K: Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity. Clin Exp Obstet Gynecol 2007; 34:207-211.
96. Srivastava MD, Thomas A, Srivastava BI, Check JH: Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma 2007; 48:1610-1617.